Master the Science of Success through aspirational coverage for executive-level decisions, leadership, management, strategy and commercialization professionals.

Medpace has historically maintained a conservative balance sheet. At year-end 2024, cash and cash equivalents totaled $669 million. Medpace generated nearly $191 million in cash flow from operating ...

The US Food and Drug Administration (FDA) recently announced a strategic roadmap to phase out animal testing requirements for ...

Pre-Clinical Drug Discovery Services Market to grow through 2035, driven by rising chronic diseases and increased outsourcing of early-stage R&D.

Pharmaceutical industry experts at Gitex Asia 2025 discuss how AI is revolutionising drug discovery, from accelerating ...

Public health activists estimate Roche earned significantly more from risdiplam, a spinal muscular atrophy drug, than its ...

The U.S. Food and Drug Administration announced earlier this month that it will be phasing out animal testing for some new ...

Pharma major Roche may have earned over a hundred times what risdiplam, a drug used to treat spinal muscular atrophy (SMA), ...

The Trump administration is proceeding with probes into the national security implications of pharmaceutical imports.

In many cases, the money flowed to addiction recovery programs that help rebuild lives by driving people to medical ...

The FDA is phasing out animal testing and moving to more human-relevant methods. This was announced as one of Marty Makary’s ...

Besides generics, Dr. Reddy’s has committed a lot of resources to develop its biosimilars as well as new chemical entity business. Biosimilars have been seen as a growth engine for large, capable ...